Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:603-610, doi:10.1016/S0735-1097(02)02898-X
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rastegar, R.
Right arrow Articles by Goldman, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rastegar, R.
Right arrow Articles by Goldman, M. E.

CLINICAL STUDY: CARDIOVASCULAR IMAGING

Spontaneous echo contrast videodensity isflow-related and is dependent on the relative concentrations of fibrinogen and red blood cells

Raymonda Rastegar, MD, FACC*, David J. Harnick, MD*, Peter Weidemann, MD*, Valentin Fuster, MD, PhD, FACC*, Barry Coller, MD*, Juan J. Badimon, PhD, FACC*, James Chesebro, MD, FACC* and Martin E. Goldman, MD, FACC*,*

* Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA

Manuscript received April 12, 2002; revised manuscript received June 20, 2002, accepted July 17, 2002.

* Reprint requests and correspondence: Dr. Martin E. Goldman, Mount Sinai Medical Center, Box 1030, One Gustave L. Levy Place, New York, New York 10029-6574, USA.
martin.goldman{at}mssm.edu

OBJECTIVES: The purposes of the present study were to: 1) determine whether fibrinogen (Fg) is the plasma protein responsible for spontaneous echo contrast (SEC), and 2) investigate modulators of SEC.

BACKGROUND: Spontaneous echo contrast has been linked to the development of thromboemboli. The blood products and their interaction responsible for SEC formation have not been fully elucidated.

METHODS: Blood echogenicity was examined with the use of quantitative videodensitometry over a controlled range of flow velocities in an in vitro model. Human blood samples were analyzed in a manner to methodically eliminate individual blood components from whole blood to determine which components are responsible for the formation of SEC.

RESULTS: The videodensity (VD) of whole blood was found to be flow-dependent, with higher VD at lower flow rates, and correlated with visually dense SEC. The following blood products produced faint VD values: washed red blood cells (wRBCs), platelet-depleted plasma, Fg, defibrinated plasma, wRBCs plus defibrinated plasma, and physiologic saline. The VD of wRBCs increased incrementally as increasing concentrations of Fg were added. At each hematocrit (Hct) range, as Fg concentration increased, the SEC became denser, and the VD level also increased until a plateau level was reached that was distinct for each Hct. The addition of sialic acid, which inhibits RBC-RBC aggregation, decreased the amount of SEC, even in the presence of Fg.

CONCLUSIONS: These results demonstrated that Fg-mediated RBC aggregation may be responsible for SEC generation. Furthermore, a unique stoichiometric relationship exists between Fg and RBC concentrations that is necessary for blood echogenicity.

Abbreviations and Acronyms
  Fg
  fibrinogen
  Hct
  hematocrit
  plt
  platelet
  RBC
  red blood cell
  SEC
  spontaneous echo contrast
  VD
  videodensity
  WBC
  white blood cell
  wRBC
  washed red blood cell




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. Doufekias, A. Z. Segal, and J. R. Kizer
Cardiogenic and aortogenic brain embolism.
J. Am. Coll. Cardiol., March 18, 2008; 51(11): 1049 - 1059.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. J. Asirvatham
Ablation for Atrial Fibrillation: Can We Decrease Thromboembolism Without Increasing the Risk for Bleeding?
Circulation, November 27, 2007; 116(22): 2517 - 2519.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Perez-Gomez, A. Salvador, J. Zumalde, J. A. Iriarte, J. Berjon, E. Alegria, C. Almeria, R. Bover, D. Herrera, C. Fernandez, et al.
Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial
Eur. Heart J., April 2, 2006; 27(8): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
W. Kosmala, P. Colonna, M. Przewlocka-Kosmala, and W. Mazurek
Right Ventricular Dysfunction in Asymptomatic Diabetic Patients
Diabetes Care, November 1, 2004; 27(11): 2736 - 2738.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-F. Ren, F. E. Marchlinski, and D. J. Callans
Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography
J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1861 - 1867.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement